With the intervention of human AD-MSC to the in vitro WD model system, we noticed a promising effect of human dASCs increasing the upregulation of CJUN protein to 1.5-fold increase at D3 compared to D3 control; and downregulation of both gene and protein expression of KROX20. This evidence concerns the gene EGR2 and Alzheimer disease.